Philip F Halloran

31PUBLICATIONS
85CO-AUTHORS
Transplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 17, 2026
Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation.

|Apr 29, 2025
Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies.

Matthias Diebold, Patrick T Gauthier, Katharina A Mayer

|Jul 18, 2024
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection.

Fabian Halleck, Georg A Böhmig, Lionel Couzi

|Apr 19, 2024
The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection.

Thibaut Vaulet, Jasper Callemeyn, Baptiste Lamarthée

|Apr 17, 2024
Epithelial cell states associated with kidney and allograft injury.

Christian Hinze, Svjetlana Lovric, Philip F Halloran

|Aug 11, 2022
Letter to the Editor Re: Letter by Naesens et al. Microvascular inflammation: Gene expression changes do not necessarily reflect pathogenesis.

Philip F Halloran, Katelynn S Madill-Thomsen

Pageof 6

Frequent Collaborators

6 joint publications

Georg A Böhmig

6 joint publications

Katelynn S Madill-Thomsen

6 joint publications

Gaurav Gupta

3 joint publications

Gunilla Einecke